O Shaughnessy Asset Management LLC Decreases Stock Position in Humana Inc. (NYSE:HUM)

O Shaughnessy Asset Management LLC decreased its position in shares of Humana Inc. (NYSE:HUM) by 45.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,890 shares of the insurance provider’s stock after selling 2,375 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Humana were worth $733,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in HUM. HighTower Advisors LLC grew its stake in Humana by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider’s stock valued at $2,852,000 after purchasing an additional 187 shares in the last quarter. IHT Wealth Management LLC grew its position in shares of Humana by 38.2% during the third quarter. IHT Wealth Management LLC now owns 1,082 shares of the insurance provider’s stock worth $334,000 after buying an additional 299 shares in the last quarter. Stifel Financial Corp increased its stake in shares of Humana by 8.8% in the third quarter. Stifel Financial Corp now owns 59,432 shares of the insurance provider’s stock worth $18,825,000 after buying an additional 4,804 shares during the last quarter. Kovitz Investment Group Partners LLC raised its holdings in Humana by 61.6% in the third quarter. Kovitz Investment Group Partners LLC now owns 4,179 shares of the insurance provider’s stock valued at $1,324,000 after acquiring an additional 1,593 shares in the last quarter. Finally, National Bank of Canada FI boosted its stake in Humana by 54.4% during the 3rd quarter. National Bank of Canada FI now owns 83,987 shares of the insurance provider’s stock valued at $26,602,000 after acquiring an additional 29,593 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

HUM opened at $280.63 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The business’s 50 day moving average is $266.00 and its 200-day moving average is $271.01. The stock has a market cap of $33.87 billion, a PE ratio of 28.20, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.26%. Humana’s payout ratio is 35.58%.

Analyst Upgrades and Downgrades

HUM has been the subject of several research analyst reports. Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Barclays upped their price objective on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Seventeen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $280.17.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.